(Q39188098)

English

Afatinib prolongs survival compared with gefitinib in an epidermal growth factor receptor-driven lung cancer model

scientific article published on 26 February 2013

Statements

Afatinib prolongs survival compared with gefitinib in an epidermal growth factor receptor-driven lung cancer model (English)
Takashi Ninomiya
Yoshihiro Honda
26 February 2013
589-597

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit